Table of Contents Chapter 1 Overview of Weight Loss Drugs 1.1 Definition of Weight Loss Drugs in This Report 1.2 Commercial Types of Weight Loss Drugs 1.2.1 Liauid 1.2.2 Tablets 1.3 Downstream Application of Weight Loss Drugs 1.3.1 Weight-reducing Aid 1.3.2 Other 1.4 Development History of Weight Loss Drugs 1.5 Market Status and Trend of Weight Loss Drugs 2013-2023 1.5.1 EMEA Weight Loss Drugs Market Status and Trend 2013-2023 1.5.2 Regional Weight Loss Drugs Market Status and Trend 2013-2023 Chapter 2 EMEA Market Status and Forecast by Regions 2.1 Market Status of Weight Loss Drugs in EMEA 2013-2017 2.2 Consumption Market of Weight Loss Drugs in EMEA by Regions 2.2.1 Consumption Volume of Weight Loss Drugs in EMEA by Regions 2.2.2 Revenue of Weight Loss Drugs in EMEA by Regions 2.3 Market Analysis of Weight Loss Drugs in EMEA by Regions 2.3.1 Market Analysis of Weight Loss Drugs in Europe 2013-2017 2.3.2 Market Analysis of Weight Loss Drugs in Middle East 2013-2017 2.3.3 Market Analysis of Weight Loss Drugs in Africa 2013-2017 2.4 Market Development Forecast of Weight Loss Drugs in EMEA 2018-2023 2.4.1 Market Development Forecast of Weight Loss Drugs in EMEA 2018-2023 2.4.2 Market Development Forecast of Weight Loss Drugs by Regions 2018-2023 Chapter 3 EMEA Market Status and Forecast by Types 3.1 Whole EMEA Market Status by Types 3.1.1 Consumption Volume of Weight Loss Drugs in EMEA by Types 3.1.2 Revenue of Weight Loss Drugs in EMEA by Types 3.2 EMEA Market Status by Types in Major Countries 3.2.1 Market Status by Types in Europe 3.2.2 Market Status by Types in Middle East 3.2.3 Market Status by Types in Africa 3.3 Market Forecast of Weight Loss Drugs in EMEA by Types Chapter 4 EMEA Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Weight Loss Drugs in EMEA by Downstream Industry 4.2 Demand Volume of Weight Loss Drugs by Downstream Industry in Major Countries 4.2.1 Demand Volume of Weight Loss Drugs by Downstream Industry in Europe 4.2.2 Demand Volume of Weight Loss Drugs by Downstream Industry in Middle East 4.2.3 Demand Volume of Weight Loss Drugs by Downstream Industry in Africa 4.3 Market Forecast of Weight Loss Drugs in EMEA by Downstream Industry Chapter 5 Market Driving Factor Analysis of Weight Loss Drugs 5.1 EMEA Economy Situation and Trend Overview 5.2 Weight Loss Drugs Downstream Industry Situation and Trend Overview Chapter 6 Weight Loss Drugs Market Competition Status by Major Players in EMEA 6.1 Sales Volume of Weight Loss Drugs in EMEA by Major Players 6.2 Revenue of Weight Loss Drugs in EMEA by Major Players 6.3 Basic Information of Weight Loss Drugs by Major Players 6.3.1 Headquarters Location and Established Time of Weight Loss Drugs Major Players 6.3.2 Employees and Revenue Level of Weight Loss Drugs Major Players 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Weight Loss Drugs Major Manufacturers Introduction and Market Data 7.1 Roche 7.1.1 Company profile 7.1.2 Representative Weight Loss Drugs Product 7.1.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Roche 7.2 GSK group 7.2.1 Company profile 7.2.2 Representative Weight Loss Drugs Product 7.2.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of GSK group 7.3 Teva 7.3.1 Company profile 7.3.2 Representative Weight Loss Drugs Product 7.3.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Teva 7.4 Sandoz(Novartis) 7.4.1 Company profile 7.4.2 Representative Weight Loss Drugs Product 7.4.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Sandoz(Novartis) 7.5 STADA-VN J.V.Co., Ltd 7.5.1 Company profile 7.5.2 Representative Weight Loss Drugs Product 7.5.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of STADA-VN J.V.Co., Ltd 7.6 Hexal AG 7.6.1 Company profile 7.6.2 Representative Weight Loss Drugs Product 7.6.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hexal AG 7.7 National Company For Pharmaceutical Industry 7.7.1 Company profile 7.7.2 Representative Weight Loss Drugs Product 7.7.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of National Company For Pharmaceutical Industry 7.8 Lunan Pharmaceutical Group Corporation 7.8.1 Company profile 7.8.2 Representative Weight Loss Drugs Product 7.8.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Lunan Pharmaceutical Group Corporation 7.9 Zein Pharmaceutical 7.9.1 Company profile 7.9.2 Representative Weight Loss Drugs Product 7.9.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Zein Pharmaceutical 7.10 Hisun 7.10.1 Company profile 7.10.2 Representative Weight Loss Drugs Product 7.10.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hisun 7.11 Taj Pharmaceuticals Ltd 7.11.1 Company profile 7.11.2 Representative Weight Loss Drugs Product 7.11.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals Ltd 7.12 Kabir Life Sciences & Research 7.12.1 Company profile 7.12.2 Representative Weight Loss Drugs Product 7.12.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Kabir Life Sciences & Research 7.13 Dm Pharma 7.13.1 Company profile 7.13.2 Representative Weight Loss Drugs Product 7.13.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Dm Pharma 7.14 China Zhongshan Pharm 7.14.1 Company profile 7.14.2 Representative Weight Loss Drugs Product 7.14.3 Weight Loss Drugs Sales, Revenue, Price and Gross Margin of China Zhongshan Pharm Chapter 8 Upstream and Downstream Market Analysis of Weight Loss Drugs 8.1 Industry Chain of Weight Loss Drugs 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Weight Loss Drugs 9.1 Cost Structure Analysis of Weight Loss Drugs 9.2 Raw Materials Cost Analysis of Weight Loss Drugs 9.3 Labor Cost Analysis of Weight Loss Drugs 9.4 Manufacturing Expenses Analysis of Weight Loss Drugs Chapter 10 Marketing Status Analysis of Weight Loss Drugs 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of Liauid Table Advantage and Disadvantage of Tablets Table Consumption Volume of Weight Loss Drugs in EMEA by Regions 2013-2017 Table Revenue of Weight Loss Drugs in EMEA by Regions 2013-2017 Table Consumption Volume of Weight Loss Drugs in EMEA by Regions 2018-2023 Table Revenue of Weight Loss Drugs in EMEA by Regions 2018-2023 Table Consumption Volume of Weight Loss Drugs in EMEA by Types 2013-2017 Table Revenue of Weight Loss Drugs in EMEA by Types 2013-2017 Table Consumption Volume of Weight Loss Drugs by Types in Europe 2013-2017 Table Consumption Volume of Weight Loss Drugs by Types in Middle East 2013-2017 Table Consumption Volume of Weight Loss Drugs by Types in Africa 2013-2017 Table Consumption Volume Forecast of Weight Loss Drugs in EMEA by Types 2018-2023 Table Revenue Forecast of Weight Loss Drugs in EMEA by Types 2018-2023 Table Demand Volume of Weight Loss Drugs in EMEA by Downstream Industry 2013-2017 Table Demand Volume of Weight Loss Drugs by Downstream Industry in Europe 2013-2017 Table Demand Volume of Weight Loss Drugs by Downstream Industry in Middle East 2013-2017 Table Demand Volume of Weight Loss Drugs by Downstream Industry in Africa 2013-2017 Table Demand Volume Forecast of Weight Loss Drugs in EMEA by Downstream Industry 2018-2023 Table Sales Volume of Weight Loss Drugs in EMEA by Major Players 2013-2017 Table Revenue of Weight Loss Drugs in EMEA by Major Players 2013-2017 Table Headquarters Location and Established Time of Weight Loss Drugs Major Players Table Employees and Revenue Level of Weight Loss Drugs Major Players Table Representative Weight Loss Drugs Product One of Roche Table Representative Weight Loss Drugs Product Two of Roche Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Roche 2013-2017 Table Representative Weight Loss Drugs Product One of GSK group Table Representative Weight Loss Drugs Product Two of GSK group Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of GSK group 2013-2017 Table Representative Weight Loss Drugs Product One of Teva Table Representative Weight Loss Drugs Product Two of Teva Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Teva 2013-2017 Table Representative Weight Loss Drugs Product One of Sandoz(Novartis) Table Representative Weight Loss Drugs Product Two of Sandoz(Novartis) Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Sandoz(Novartis) 2013-2017 Table Representative Weight Loss Drugs Product One of STADA-VN J.V.Co., Ltd Table Representative Weight Loss Drugs Product Two of STADA-VN J.V.Co., Ltd Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of STADA-VN J.V.Co., Ltd 2013-2017 Table Representative Weight Loss Drugs Product One of Hexal AG Table Representative Weight Loss Drugs Product Two of Hexal AG Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hexal AG 2013-2017 Table Representative Weight Loss Drugs Product One of National Company For Pharmaceutical Industry Table Representative Weight Loss Drugs Product Two of National Company For Pharmaceutical Industry Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of National Company For Pharmaceutical Industry 2013-2017 Table Representative Weight Loss Drugs Product One of Lunan Pharmaceutical Group Corporation Table Representative Weight Loss Drugs Product Two of Lunan Pharmaceutical Group Corporation Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Lunan Pharmaceutical Group Corporation 2013-2017 Table Representative Weight Loss Drugs Product One of Zein Pharmaceutical Table Representative Weight Loss Drugs Product Two of Zein Pharmaceutical Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Zein Pharmaceutical 2013-2017 Table Representative Weight Loss Drugs Product One of Hisun Table Representative Weight Loss Drugs Product Two of Hisun Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Hisun 2013-2017 Table Representative Weight Loss Drugs Product One of Taj Pharmaceuticals Ltd Table Representative Weight Loss Drugs Product Two of Taj Pharmaceuticals Ltd Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Taj Pharmaceuticals Ltd 2013-2017 Table Representative Weight Loss Drugs Product One of Kabir Life Sciences & Research Table Representative Weight Loss Drugs Product Two of Kabir Life Sciences & Research Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Kabir Life Sciences & Research 2013-2017 Table Representative Weight Loss Drugs Product One of Dm Pharma Table Representative Weight Loss Drugs Product Two of Dm Pharma Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of Dm Pharma 2013-2017 Table Representative Weight Loss Drugs Product One of China Zhongshan Pharm Table Representative Weight Loss Drugs Product Two of China Zhongshan Pharm Table Weight Loss Drugs Sales, Revenue, Price and Gross Margin of China Zhongshan Pharm 2013-2017